These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 624504)

  • 1. Assessment of the (14C) aminopyrine breath test in liver disease.
    Galizzi J; Long RG; Billing BH; Sherlock S
    Gut; 1978 Jan; 19(1):40-5. PubMed ID: 624504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The diagnostic relevance of the aminopyrine breath test in liver disease].
    Wildgrube HJ; Stang H
    Z Gastroenterol; 1982 Nov; 20(11):667-72. PubMed ID: 7180067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple method for routine determination of the metabolic liver capacity: the aminopyrine breath test.
    Haustein KO; Schenker E
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):190-6. PubMed ID: 3922902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.
    Fasoli A; Giannini E; Botta F; Romagnoli P; Risso D; Celle G; Testa R
    Hepatogastroenterology; 2000; 47(31):234-8. PubMed ID: 10690614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease.
    Schneider JF; Baker AL; Haines NW; Hatfield G; Boyer JL
    Gastroenterology; 1980 Dec; 79(6):1145-50. PubMed ID: 6777231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [14C]Aminopyrine breath test in chronic liver disease: preliminary diagnostic implications.
    Burnstein AV; Galambos JT
    Dig Dis Sci; 1981 Dec; 26(12):1078-83. PubMed ID: 7307854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experiences with the 14C-aminopyrine breath test in liver cirrhosis and under the effect of sodium diclofenac (Voltaren)].
    Reinicke C; Eitner K; Hippius M; Krombholz B; Stiller KJ; Wächter G
    Dtsch Z Verdau Stoffwechselkr; 1983; 43(3):117-29. PubMed ID: 6603964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14C-D-galactose breath test for evaluation of liver function in patients with chronic liver disease.
    Caspary WF; Schäffer J
    Digestion; 1978; 17(5):410-8. PubMed ID: 680418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of [14C]aminopyrine breath test, peripheral clearance of [99mTc]EHIDA, and serum bile acid levels in liver function and disease.
    Nikopoulos A; Giannoulis E; Doutsos I; Grammaticos P; Tourkantonis A; Arvanitakis C
    Dig Dis Sci; 1992 Nov; 37(11):1655-60. PubMed ID: 1425063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breath 14CO2 after intravenous administration of [14C]aminopyrine in liver diseases.
    Pauwels S; Geubel AP; Dive C; Beckers C
    Dig Dis Sci; 1982 Jan; 27(1):49-56. PubMed ID: 6802621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between aminopyrine breath test and severity of liver disease in cirrhosis.
    Morelli A; Narducci F; Pelli MA; Farroni F; Vedovelli A
    Am J Gastroenterol; 1981 Aug; 76(2):110-3. PubMed ID: 6795921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aminopyrine breath test does not correlate with histologic disease severity in patients with cholestasis.
    Baker AL; Krager PS; Kotake AN; Schoeller DA
    Hepatology; 1987; 7(3):464-7. PubMed ID: 3570158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminopyrine demethylation measured by breath analysis in cirrhosis.
    Bircher J; Küpfer A; Gikalov I; Preisig R
    Clin Pharmacol Ther; 1976 Oct; 20(4):484-92. PubMed ID: 975720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 13C-aminopyrine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection.
    Giannini E; Fasoli A; Chiarbonello B; Malfatti F; Romagnoli P; Botta F; Testa E; Polegato S; Fumagalli A; Testa R
    Aliment Pharmacol Ther; 2002 Apr; 16(4):717-25. PubMed ID: 11929389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assessment of hepatic function by breath analysis after oral administration of (14C)aminopyrine.
    Hepner GW; Vesell ES
    Ann Intern Med; 1975 Nov; 83(5):632-8. PubMed ID: 1200495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 30-minute aminopyrine breath test: optimization of sampling times after intravenous administration of 14C-aminopyrine.
    Miotti T; Bircher J; Preisig R
    Digestion; 1988; 39(4):241-50. PubMed ID: 3220177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminopyrine disposition: studies on breath, saliva, and urine of normal subjects and patients with liver disease.
    Hepner GW; Vesell ES
    Clin Pharmacol Ther; 1976 Dec; 20(6):654-60. PubMed ID: 991536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of antithrombin III and aminopyrine breath test in liver disease.
    Rodzynek JJ; Preux C; Leautaud P; Abramovici J; Di Paolo A; Delcourt AA
    Arch Intern Med; 1986 Apr; 146(4):677-80. PubMed ID: 3963948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
    von Mandach U; Jost G; Preisig R
    Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminopyrine breath test: development of a 13C-breath test for quantitative assessment of liver function in humans.
    Mion F; Queneau PE; Rousseau M; Brazier JL; Paliard P; Minaire Y
    Hepatogastroenterology; 1995; 42(6):931-8. PubMed ID: 8847048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.